Precipio Market Cap 2010-2025 | PRPO

Precipio market cap history and chart from 2010 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Precipio market cap as of May 16, 2025 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.012B $0.019B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.36
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.156B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00